5 March 2024 · Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.
16 December 2016 · Variation in practice underlined the need for an evidence-based guideline for handling mAbs that was suited to all those providing care to NHS patients.
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
9 September 2020 · Advice on the legal labelling requirements for Prescription Only Medicines (POM) and Pharmacy Medicines (P) supplied under a Patient Group Direction
11 February 2020 · Annual lists of new products and formulations that have launched, and had licence changes approved. Usually published each February.
5 March 2018 · These Good Practice Principles set out the National Homecare Medicines Committee’s (NHMC) expectations of Manufacturers offering Manufacturer Funded Homecare Medicine Services in relation to the…